SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
SEATTLE, Washington
Total Received
$76.8M
Total Awards
41
State
Washington
Last Updated
Mar 20, 2026
Yearly Funding Trend
$69.4M24
$6.9M25
$525K26
Top 41 Awards to SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U01DK048413_075 8/22 LIMITED COMPETITION FOR THE CONTINUATION OF THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) - CLINICAL CENTER - ABNORMAL REGULATION OF GLYCEMIA (“DYSGLYCEMIA”) HAS A V… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SEATTLE, WA-09 | 2024 | $8,255,573 |
ASST_NON_R01NS064131_075 DEVELOPING NEUROPROTECTIVE STRATEGIES FOR TAU AND TDP-43 PROTEINOPATHY IN FTLD - NEURONAL LESIONS CONTAINING EITHER ABNORMAL PATHOLOGICAL TAU OR ABNORMAL PATHOLOGICAL TDP-43 PROTE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | WA-90 | 2024 | $4,975,854 |
CONT_AWD_W81XWH20C0116_9700_-NONE-_-NONE- DEVELOPMENT OF F-18 LABELED RADIOTRACERS FOR PET IMAGING OF BRAIN ALPHA1A ADRENOCEPTOR- A TOOL FOR PRECISION MEDICINE IN POST TRAUMATIC STRESS DISCORDER | Department of Defense Defense Health Agency | — | SEATTLE, WA-09 | 2024 | $4,452,838 |
ASST_NON_R01AG075338_075 ROLE OF ASTROCYTE EAAT2/GLT1 FAILURE IN ALZHEIMER'S DISEASE PATHOGENESIS - ASTROCYTES ARE IDEALLY POSITIONED TO SUPPORT NEURONAL/SYNAPTIC NEEDS FOR TROPHIC FACTORS, METABOLIC HOME… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | ALBANY, NY-20 | 2024 | $3,778,626 |
ASST_NON_R01AG061558_075 IMPROVING CANCER-RELATED FATIGUE, SEXUAL DYSFUNCTION AND QUALITY OF LIFE IN OLDER MEN WITH CANCER AND ANDROGEN DEFICIENCY - PROJECT SUMMARY BY THE YEAR 2050, THE NUMBER OF INDIVID… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $3,397,618 |
ASST_NON_R01CA239208_075 IMPROVING PATIENT-IMPORTANT OUTCOMES WITH TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN WITH A PRIOR HISTORY OF CANCER - PROJECT SUMMARY/ABSTRACT THE OVERALL GOAL OF THIS PROPOSAL I… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SEATTLE, WA-09 | 2024 | $3,302,289 |
ASST_NON_R01CA243907_075 IMPROVING THE REACH AND EFFECTIVENESS OF SMOKING CESSATION SERVICES TARGETED TO VETERANS LIVING WITH HIV - PROJECT SUMMARY TOBACCO USE REMAINS THE LEADING PREVENTABLE CAUSE OF DE… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SEATTLE, WA-09 | 2024 | $3,061,121 |
ASST_NON_U01HL142103_075 ADVANCING HIGH QUALITY COPD CARE FOR PEOPLE WITH IMMUNE DYSFUNCTION BY IMPLEMENTING EVIDENCE-BASED MANAGEMENT THROUGH PROACTIVE E-CONSULTS (ACHIEVE) - ABSTRACT AS HIV-INFECTED (HI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2024 | $2,769,757 |
ASST_NON_R01AG066211_075 PROTECTION FROM PATHOLOGICAL TAU BY ACTIVATION OF THE ER UNFOLDED PROTEIN RESPONSE - PATHOLOGICAL DEPOSITION OF ABNORMAL AGGREGATED TAU PROTEIN IN NEURONS IS ONE OF THE DIAGNOSTIC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $2,657,776 |
ASST_NON_R01AG066729_075 TDP-43 IN ALZHEIMER'S DISEASE - ALZHEIMER’S DISEASE, A SEVERE PROGRESSIVE NEURODEGENERATIVE DISEASE OF AGING AND THE MOST COMMON FORM OF DEMENTIA, AFFECTS AN ESTIMATED 30 MILLION… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $2,612,954 |
ASST_NON_RF1AG059088_075 EFFECTS OF APOE ISOFORM, SEX AND DIET ON INSULIN REGULATION IN BRAIN - PROJECT SUMMARY SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS (SARS-COV-2) CAUSES A WORLD-WIDE PANDEMIC INVO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $2,492,167 |
ASST_NON_R33AG064271_075 USE OF WEARABLE SENSORS TO IMPROVE THE EARLY DIAGNOSIS OF DLB - PROJECT SUMMARY/ABSTRACT DEMENTIA WITH LEWY BODIES (DLB) IS DIFFICULT TO DIAGNOSE EARLY IN ITS DISEASE COURSE DUE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | WA-90 | 2024 | $2,159,966 |
ASST_NON_W81XWH2010291_097 A PROSTHETIC FOOT TEST-DRIVE STRATEGY FOR IMPROVING STABILITY AND FALLS-RELATED OUTCOMES IN VETERANS WITH LEG AMPUTATIONS THIS MODIFICATION: 1. EXTENDS THE POP BY 12 MONTHS; THE F… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2024 | $2,000,000 |
ASST_NON_R01MH116883_075 GENETIC DISSECTION OF CATECHOLAMINERGIC INNERVATION OF THE COGNITIVE CEREBELLUM - STUDIES IN HUMANS AND NON-HUMAN PRIMATES HAVE IDENTIFIED A REGION OF THE DENTATE NUCLEUS OF THE C… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | WA-90 | 2025 | $1,960,848 |
ASST_NON_R01NS119897_075 INVESTIGATING THE ROLE OF LIPID METABOLISM IN PROTEIN AGGREGATION AND NEURODEGENERATIVE DISEASE PROGRESSION - PROJECT SUMMARY PATHOGENIC PROTEIN AGGREGATES ARE A HALLMARK NEUROPA… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | WA-90 | 2024 | $1,957,052 |
ASST_NON_R01AG084680_075 FORMATION OF TAU RNA COMPLEXES DISRUPTS TAU FUNCTION AND DRIVES TAU NEUROPATHOLOGY - PATHOLOGICAL TAU PROTEIN ACCUMULATES IN NEURONAL LESIONS AND CONSTITUTES ONE OF THE DEFINING D… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $1,947,127 |
ASST_NON_R01DA052618_075 MICROGLIA AND OPIOID WITHDRAWAL: MECHANISMS OF NEGATIVE REINFORCEMENT - THE CURRENT EPIDEMIC OF OPIOID OVERDOSES HAS BEEN PROPELLED BY BOTH ILLICIT AND PRESCRIBED NARCOTIC PAIN ME… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | SEATTLE, WA-09 | 2024 | $1,910,647 |
ASST_NON_R01DK132355_075 CIRCULATING MIRNAS AND PREDICTION OF BETA-CELL TREATMENT RESPONSE: THE RESTORING INSULIN SECRETION STUDY - ABSTRACT DESPITE TREATMENT, A SIGNIFICANT PROPORTION OF PATIENTS WITH TY… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | WA-90 | 2024 | $1,899,673 |
ASST_NON_R01AG054456_075 DEFINING THE ROLE OF AGE-RELATED GLYMPHATIC PATHWAY IMPAIRMENT IN AMYLOID BETA PLAQUE DEPOSITION - SUMMARY ABSTRACT ALZHEIMER'S DISEASE (AD) IS THE LEADING CAUSE OF DEMENTIA WORLD… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $1,815,788 |
ASST_NON_R01NS129573_075 ROLE OF SLEEP DISRUPTION AFTER MTBI AS A DRIVER OF CHRONIC POST-TRAUMATIC HEADACHE - PROJECT SUMMARY/ABSTRACT MIGRAINE-LIKE HEADACHES ARE AMONG THE MOST FREQUENT COMPLAINTS FOLLOW… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | SEATTLE, WA-09 | 2024 | $1,798,407 |
ASST_NON_R01DK133317_075 ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN GLUCOSE HOMEOSTASIS - PROJECT SUMMARY/ABSTRACT IN TREATING TYPE 2 DIABETES (T2D), THERE IS A PAUCITY OF MEDICATIONS SIMULTANEOUSLY TARGETI… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SEATTLE, WA-09 | 2024 | $1,521,418 |
ASST_NON_R01CA279220_075 SARCOPENIA IN MEN WITH PROSTATE CANCER UNDERGOING ADT (SAP-ADT) - PROJECT SUMMARY/ABSTRACT A DECREASE IN MUSCLE MASS AND FUNCTION, KNOWN AS SARCOPENIA, IS HIGHLY PREVALENT IN CANC… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SEATTLE, WA-09 | 2024 | $1,445,292 |
ASST_NON_R01AR076475_075 CHARACTERIZING AND RESTORING JOINT MOTION IN PATIENTS WITH HALLUX RIGIDUS - PROJECT SUMMARY/ABSTRACT THE FIRST METATARSOPHALANGEAL JOINT (MTPJ1) IS ONE OF THE SITES MOST OFTEN AFF… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | WA-90 | 2024 | $1,433,768 |
ASST_NON_R01DK115976_075 ROLE OF BROWN ADIPOSE TISSUE THERMOGENESIS IN OXYTOCIN-ELICITED WEIGHT LOSS - PROJECT SUMMARY/ABSTRACT WE AND OTHERS HAVE SHOWN THAT THE NONAPEPTIDE, OXYTOCIN (OT), CIRCUMVENTS LE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SEATTLE, WA-09 | 2024 | $1,413,526 |
ASST_NON_R01NS128966_075 DEFINING THE ROLE OF POST-TBI SLEEP DISRUPTION IN THE DEVELOPMENT OF CTE AND ALZHEIMER'S DISEASE-RELATED NEUROPATHOLOGY - ABSTRACT MILD TRAUMATIC BRAIN INJURY (MTBI, CONCUSSION) H… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | WA-90 | 2025 | $1,253,356 |
ASST_NON_R01DK134502_075 EFFECTS OF CHOLESTEROL IN PANCREATIC ISLETS - PROJECT SUMMARY/ABSTRACT STATINS ARE THE MOST COMMONLY USED CHOLESTEROL-LOWERING MEDICATION; HOWEVER, STATINS INCREASE THE RISK OF N… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SEATTLE, WA-09 | 2024 | $1,218,618 |
ASST_NON_R01AG084552_075 INVESTIGATING HOW SUT-6/NIPP1 REGULATES PATHOLOGICAL TAU - BACKGROUND: ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DISEASES WITH ACCUMULATION OF PATHOLOGICAL TAU PROTEIN, TERM… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $1,126,937 |
ASST_NON_W81XWH1810461_097 THE ROLE OF MITOCHONDRIA IN ADT-INDUCED SARCOPENIA IN PROSTATE CANCER PATIENTS. THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDS IN THE AMOUNT OF $2,323.60. THIS IS IN ACCO… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2025 | $1,069,689 |
ASST_NON_R61AG080614_075 TAI CHI PRACTICE AND SLEEP-ACTIVE GLYMPHATIC FUNCTION - PROJECT SUMMARY/ABSTRACT AMYLOID PLAQUE DEPOSITION, A KEY PATHOLOGICAL HALLMARK OF ALZHEIMER’S DISEASE (AD), BEGINS 1-2 DEC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | WA-90 | 2024 | $964,229 |
ASST_NON_R01HL179905_075 OPTIMIZING MEDICATIONS AND LUNG HEALTH IN PEOPLE WITH HIV THROUGH PHARMACIST-LED PROACTIVE E-CONSULTS (OPTIMIZE LUNG-HIV) - PROJECT SUMMARY/ABSTRACT DESPITE EFFECTIVE ANTIRETROVIR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | WA-90 | 2025 | $803,801 |
ASST_NON_W81XWH1910809_097 MEDICAL ADRENALECTOMY TO ABROGATE LIGAND PRODUCTION IN CASTRATION-RESISTANT PROSTATE CANCER. 1. AWARD IS TO DE-OBLIGATE UNDISBURSED FUNDS IN THE AMOUNT OF $2,868.97. THE TOTAL AWA… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2024 | $789,731 |
ASST_NON_W81XWH2211114_097 EFFICACY OF VIRTUAL WARRIOR RENEW THERAPY FOR VETERANS WHO EXPERIENCED MILITARY SEXUAL TRAUMA EXTEND THE PERIOD OF PERFORMANCE AND REMOVES PAYMENT RESTRICTION CLAUSE. HUMAN USE AP… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2025 | $749,967 |
ASST_NON_HT94252410776_097 GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2024 | $674,746 |
ASST_NON_R00AG073455_075 MUTANT TUBULINS CONFER RESISTANCE TO PATHOLOGICAL TAU - PROJECT SUMMARY/ABSTRACT PATHOLOGICAL TAU IS PRESENT IN A NUMBER OF AGE-RELATED DISEASES (TAUOPATHIES) INCLUDING ALZHEIMER… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $545,780 |
ASST_NON_R01AR078487_075 HELPING PATIENTS AND PHYSICIANS CHOOSE THE APPROPRIATE SURGERY FOR END STAGE HALLUX RIGIDUS - PROJECT SUMMARY/ABSTRACT THE PRIMARY OBJECTIVE OF THIS PROJECT IS TO OBTAIN OBSERVATI… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | WA-90 | 2026 | $525,424 |
ASST_NON_R21AG065928_075 CHARACTERIZATION OF A HUMAN IN VITRO BLOOD-BRAIN BARRIER MODEL TO STUDY THE EFFECTS OF SYSTEMIC AGING ON RESPONSES TO ALZHEIMER'S DISEASE EFFECTORS - PROJECT SUMMARY/ABSTRACT: AGI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SEATTLE, WA-09 | 2024 | $373,257 |
ASST_NON_R21NS118476_075 INVESTIGATING A NEUROPROTECTIVE ROLE OF GBA IN ASTROCYTES - A KEY FEATURE OF PARKINSON’S DISEASE (PD) IS ABNORMAL PROTEIN AGGREGATION WITHIN NEURONS IN THE BRAIN. THESE NEURONAL P… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | WA-90 | 2025 | $365,368 |
ASST_NON_R21MH137701_075 GRABBING SEROTONIN DURING FEAR - SEROTONIN PLAYS A CRITICAL ROLE IN RESPONDING TO POTENTIALLY THREATENING STIMULI AND MODULATING THE SEROTONIN SYSTEM CAN EITHER EXACERBATE OR AMEL… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | WA-90 | 2025 | $359,433 |
ASST_NON_R21AA029601_075 THE UNFOLDING ROLE OF MICROGLIA IN ALCOHOL WITHDRAWAL - ABSTRACT ALCOHOL WITHDRAWAL IS A MEDICAL EMERGENCY AND A BEHAVIORAL BARRIER TO REDUCING ALCOHOL ABUSE. UNLIKE WITHDRAWAL TO… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | WA-90 | 2025 | $357,526 |
ASST_NON_R21MH123840_075 USER-CENTERED DESIGN AND EVALUATION OF A VIRTUAL HUMAN PATIENT TO IMPROVE SAFETY PLANNING SKILLS - PROJECT SUMMARY DESPITE UNPRECEDENTED SUICIDE PREVENTION EFFORTS UNDERTAKEN IN T… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | WA-90 | 2024 | $354,960 |
ASST_NON_W81XWH1810153_097 ORAL GUCY2C LIGAND BLOCKS COLORECTAL TUMOR PROGRESSION IN PATIENTS. EXTENDS THE POP BY 12 MONTHS. | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SEATTLE, WA-09 | 2024 | $246,241 |
Top 41 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.866 — AGING RESEARCH$25.1M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$14.6M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$9.1M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$6.1M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$5.5M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$3.6M
93.242 — MENTAL HEALTH RESEARCH GRANTS$2.7M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$2.0M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$1.9M
93.395 — CANCER TREATMENT RESEARCH$1.4M
Source: USAspending.gov · All Recipients · Washington